Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Piperine
Therapeutic Area : Immunology
Study Phase : Undisclosed
Sponsor : Brightseed, Inc
Deal Size : Inapplicable
Deal Type : Inapplicable
Oral Supplementation With a Black Pepper Extract
Details : Undisclosed
Product Name : Undisclosed
Product Type : Plant Extract/Herbal
Upfront Cash : Inapplicable
January 20, 2022
Lead Product(s) : Piperine
Therapeutic Area : Immunology
Highest Development Status : Undisclosed
Sponsor : Brightseed, Inc
Deal Size : Inapplicable
Deal Type : Inapplicable